Advertisement
Screener

PHARMAGEN, INC. Revenue

PHARMAGEN, INC. Revenue

PHARMAGEN, INC. reported Revenue of $4.81 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.

Discontinued › Income Statement › Revenue

us-gaap:Revenues · last filed 2014-03-31

  • PHARMAGEN, INC. revenues for the quarter ending 2013-12-31 was $1.04M, a 2.83% increase year-over-year.
  • PHARMAGEN, INC. revenues for the quarter ending 2013-09-30 was $1.07M, a 39.71% decline year-over-year.
  • PHARMAGEN, INC. revenues for the quarter ending 2013-06-30 was $974.99K, a 1.25% decline year-over-year.
  • PHARMAGEN, INC. revenues for the quarter ending 2013-03-31 was $1.72M, a 259.98% increase year-over-year.
  • PHARMAGEN, INC. revenues for fiscal 2013 was $4.81M, a 12.97% increase from fiscal 2012.
  • PHARMAGEN, INC. revenues for fiscal 2012 was $4.26M, a 589.58% increase from fiscal 2011.
  • PHARMAGEN, INC. revenues for fiscal 2011 was $617.85K.
Period endRevenues 3 monthRevenues 3 month as first filedRevenues 6 monthRevenues 9 monthRevenues 9 month as first filedRevenues 12 monthRevenues 12 month as first filedRevenues 27 monthRevenues 30 month
2013-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$2.12M
derived: sum of 2 quarters · filed 2014-03-31
$3.09M
derived: sum of 3 quarters · filed 2014-03-31
$4.81M
10-K · filed 2014-03-31
2013-09-30$1.07M
10-Q · filed 2013-11-14
$2.05M
derived: sum of 2 quarters · filed 2013-11-14
$3.77M
10-Q · filed 2013-11-14
$4.78M
derived: sum of 4 quarters · filed 2014-03-31
2013-06-30$974.99K
10-Q · filed 2013-08-14
$2.70M
10-Q · filed 2013-08-14
$3.71M
derived: sum of 3 quarters · filed 2014-03-31
$5.49M
derived: sum of 4 quarters · filed 2014-03-31
2013-03-31$1.72M
10-Q · filed 2013-05-15
$2.74M
derived: sum of 2 quarters · filed 2014-03-31
$4.52M
derived: sum of 3 quarters · filed 2014-03-31
$5.50M
derived: sum of 4 quarters · filed 2014-03-31
2012-12-31$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$2.80M
derived: sum of 2 quarters · filed 2014-03-31
$3.78M
derived: sum of 3 quarters · filed 2014-03-31
$4.26M
10-K · filed 2014-03-31
$3.94M
10-K · filed 2013-04-01
2012-09-30$1.78M
10-Q · filed 2013-11-14
$2.77M
derived: sum of 2 quarters · filed 2013-11-14
$3.25M
10-Q · filed 2013-11-14
$3.06M
10-Q · filed 2012-11-14
$3.25M
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30$987.36K
10-Q · filed 2013-08-14
$1.47M
10-Q · filed 2013-08-14
$1.47M
derived: sum of 3 quarters · filed 2013-08-14
$1.65M
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$478.17K
10-Q · filed 2013-05-15
$478.17K
derived: sum of 2 quarters · filed 2013-05-15
$666.87K
derived: sum of 3 quarters · filed 2013-05-15
$714.87K
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$0.00
10-Q · filed 2012-02-13
$0.00
10-Q · filed 2012-02-13
$236.69K
derived: sum of 3 quarters · filed 2012-11-14
$617.85K
10-K · filed 2013-04-01
$262.00
10-Q · filed 2012-02-13
2011-09-30$188.69K
10-Q · filed 2012-11-14
$0.00
10-Q · filed 2011-11-14
$236.69K
derived: sum of 2 quarters · filed 2012-11-14
$182.92K
10-Q · filed 2012-11-14
$260.29K
derived: sum of 4 quarters · filed 2012-11-14
$262.00
10-Q · filed 2011-11-14
2011-06-30$48.00K
10-Q/A · filed 2012-09-14
$71.60K
10-Q/A · filed 2012-09-14
$71.60K
derived: sum of 3 quarters · filed 2012-09-14
$71.60K
derived: sum of 4 quarters · filed 2012-09-14
2011-03-31$23.60K
10-Q · filed 2012-06-11
$23.60K
derived: sum of 2 quarters · filed 2012-06-11
$23.60K
derived: sum of 3 quarters · filed 2012-06-11
2010-12-31$0.00
10-Q · filed 2012-02-13
$0.00
10-Q · filed 2012-02-13
2010-09-30$0.00
10-Q · filed 2011-11-14